Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Roger Pomerantz
24 Jan 2018
President and CEO
Exercised, kept
40,241
$0.71
$28.57K
Roger Pomerantz
18 Jul 2017
President and CEO
Exercised, kept
100,604
$0.71
$71.43K

What was left out

Form 4 filings counted 278
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 9,854,506
Sales filed before the plan box existed 20
History held since 29 Jun 2015